𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemoprevention of hepatocellular carcinoma: Use of tamoxifen in an animal model of hepatocarcinogenesis

✍ Scribed by Adrian M. Di Bisceglie; Patricia Osmack; Elizabeth M. Brunt

Book ID
113772602
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
142 KB
Volume
145
Category
Article
ISSN
1532-6543

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of tamoxifen in advanced-stage hepat
Use of tamoxifen in advanced-stage hepatocellular carcinoma : A systematic review
✍ Anna K. Nowak; Martin R. Stockler; Pierce K. H. Chow; Michael Findlay πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 126 KB

## Abstract ## BACKGROUND Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide. Survival is poor for patients with advanced‐stage HCC, and small trials of tamoxifen for patients with this disease have shown conflicting results. The authors conducted a systema

S-adenosylmethionine in the chemoprevent
S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model
✍ Shelly C. Lu; Komal Ramani; Xiaopeng Ou; Mark Lin; Victor Yu; Kwangsuk Ko; Ryan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 738 KB

Hepatocellular carcinoma (HCC) remains a common cancer worldwide that lacks effective chemoprevention or treatment. Chronic liver disease often leads to impaired hepatic S-adenosylmethionine (SAMe) biosynthesis, and mice with SAMe deficiency develop HCC spontaneously. SAMe is antiapoptotic in normal